Involvement of the Gut Microbiome in the Local and Systemic Immune Response to Pancreatic Ductal Adenocarcinoma
- PMID: 38473357
- PMCID: PMC10930865
- DOI: 10.3390/cancers16050996
Involvement of the Gut Microbiome in the Local and Systemic Immune Response to Pancreatic Ductal Adenocarcinoma
Abstract
The systemic and local immunosuppression exhibited by pancreatic ductal adenocarcinoma (PDAC) contributes significantly to its aggressive nature. There is a need for a greater understanding of the mechanisms behind this profound immune evasion, which makes it one of the most challenging malignancies to treat and thus one of the leading causes of cancer death worldwide. The gut microbiome is now thought to be the largest immune organ in the body and has been shown to play an important role in multiple immune-mediated diseases. By summarizing the current literature, this review examines the mechanisms by which the gut microbiome may modulate the immune response to PDAC. Evidence suggests that the gut microbiome can alter immune cell populations both in the peripheral blood and within the tumour itself in PDAC patients. In addition, evidence suggests that the gut microbiome influences the composition of the PDAC tumour microbiome, which exerts a local effect on PDAC tumour immune infiltration. Put together, this promotes the gut microbiome as a promising route for future therapies to improve immune responses in PDAC patients.
Keywords: gut microbiome; immunosuppression; pancreatic ductal adenocarcinoma; tumour microbiome.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
The Emerging Role of Microbiota and Microbiome in Pancreatic Ductal Adenocarcinoma.Biomedicines. 2020 Dec 3;8(12):565. doi: 10.3390/biomedicines8120565. Biomedicines. 2020. PMID: 33287196 Free PMC article. Review.
-
The Role of the Microbiome in Pancreatic Cancer.Cancers (Basel). 2022 Sep 15;14(18):4479. doi: 10.3390/cancers14184479. Cancers (Basel). 2022. PMID: 36139638 Free PMC article. Review.
-
Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma.Mol Cancer. 2023 Jul 24;22(1):118. doi: 10.1186/s12943-023-01813-y. Mol Cancer. 2023. PMID: 37488598 Free PMC article. Review.
-
A Comprehensive Review of the Current and Future Role of the Microbiome in Pancreatic Ductal Adenocarcinoma.Cancers (Basel). 2022 Feb 17;14(4):1020. doi: 10.3390/cancers14041020. Cancers (Basel). 2022. PMID: 35205769 Free PMC article. Review.
-
Targeting the metabolism and immune system in pancreatic ductal adenocarcinoma: Insights and future directions.Cytokine Growth Factor Rev. 2023 Jun-Aug;71-72:26-39. doi: 10.1016/j.cytogfr.2023.06.006. Epub 2023 Jun 30. Cytokine Growth Factor Rev. 2023. PMID: 37407355 Review.
Cited by
-
Unraveling the gut microbiome's contribution to pancreatic ductal adenocarcinoma: mechanistic insights and therapeutic perspectives.Front Immunol. 2024 Jul 9;15:1434771. doi: 10.3389/fimmu.2024.1434771. eCollection 2024. Front Immunol. 2024. PMID: 39044834 Free PMC article. Review.
-
The human microbiota: a double-edged sword against the 'Sword of Damocles' in PDAC diagnosis and therapy.Front Oncol. 2025 Jun 26;15:1519277. doi: 10.3389/fonc.2025.1519277. eCollection 2025. Front Oncol. 2025. PMID: 40641932 Free PMC article. Review.
-
Dysbiosis-NK Cell Crosstalk in Pancreatic Cancer: Toward a Unified Biomarker Signature for Improved Clinical Outcomes.Int J Mol Sci. 2025 Jan 16;26(2):730. doi: 10.3390/ijms26020730. Int J Mol Sci. 2025. PMID: 39859442 Free PMC article. Review.
References
-
- Lederberg J., McCray A.T. `Ome Sweet `Omics—A Genealogical Treasury of Words. Scientist. 2001;15:8.
Publication types
LinkOut - more resources
Full Text Sources